# Giant Malignant Phyllodes Tumor with Secondary Thyroid Involvement

**Authors:** Daciana Grujic, Teodora Hoinoiu, Catalin-Alexandru Pirvu, Mihai Iliescu-Glaja, Simona Cerbu, Silviu Cristian Suciu, Daniel Pit, Cristina Marinela Oprean, Horia Cristian

PMC · DOI: 10.3390/diseases14030114 · 2026-03-22

## TL;DR

A rare case of a large malignant breast tumor leading to thyroid metastasis highlights the aggressive nature of phyllodes tumors and the need for close monitoring.

## Contribution

This case report presents an exceptionally rare instance of thyroid metastasis from a malignant phyllodes tumor in an adult.

## Key findings

- A 5 kg malignant phyllodes tumor was surgically removed from a 47-year-old woman.
- Five months post-surgery, the patient developed metastases involving the thyroid and trachea.
- The case emphasizes the unpredictable and aggressive behavior of malignant phyllodes tumors.

## Abstract

Background/Objectives: Phyllodes tumors are rare fibroepithelial neoplasms of the breast, accounting for less than 1% of all breast tumors and approximately 2–3% of breast fibroepithelial tumors. They can be benign, borderline, or malignant, depending on cellular atypia and stromal invasion. Although most display local behavior, malignant forms can metastasize hematogenously, most frequently to the lungs, bones, and liver, with lymph node metastases being exceptional. Case Presentation: We analyzed the case of a 47-year-old woman with a phyllodes breast tumor weighing approximately 5 kg. The tumor evolved slowly over five years, followed by accelerated growth, cutaneous necrosis, superinfection, and severe anemia. Total mastectomy was performed, and histopathological examination confirmed the diagnosis of a malignant phyllodes tumor. Five months after surgery and adjuvant radiotherapy, the patient developed laterocervical metastases with thyroid invasion and life-threatening tracheal compression, an extremely rare presentation for this type of tumor in adults. Discussion/Conclusions: This case illustrates the aggressive and unpredictable behavior of malignant phyllodes tumors and underscores the necessity of careful oncological monitoring and a multidisciplinary approach, given their potential for dissemination to unusual locations.

## Linked entities

- **Diseases:** phyllodes tumor (MONDO:0005078), malignant phyllodes tumor (MONDO:0037003), anemia (MONDO:0002280)

## Full-text entities

- **Genes:** KRT5 (keratin 5) [NCBI Gene 3852] {aka CK5, DDD, DDD1, EBS1, EBS2, EBS2A}, CD34 (CD34 molecule) [NCBI Gene 947], TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, TERT (telomerase reverse transcriptase) [NCBI Gene 7015] {aka CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1}, MED12 (mediator complex subunit 12) [NCBI Gene 9968] {aka ARC240, CAGH45, FGS1, HDKR, HOPA, Kto}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ADA2 (adenosine deaminase 2) [NCBI Gene 51816] {aka ADGF, CECR1, IDGFL, PAN, SNEDS, VAIHS}, NF1 (neurofibromin 1) [NCBI Gene 4763] {aka NFNS, VRNF, WSS}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, TP63 (tumor protein p63) [NCBI Gene 8626] {aka AIS, B(p51A), B(p51B), EEC3, KET, LMS}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}
- **Diseases:** ptosis (MESH:C564553), mammary gland tumors (MESH:D015674), liver dysfunction (MESH:D017093), tumorigenic (MESH:D002471), Malignant Phyllodes Tumor (MESH:C549759), respiratory complications (MESH:D012140), Thyroid (MESH:D013966), sarcomatoid (MESH:D002292), cutaneous necrosis (MESH:D009336), inflammatory syndrome (MESH:D018746), anemia (MESH:D000740), lymphadenopathy (MESH:D008206), thyroid Hurthle cell adenoma (MESH:C536913), breast fibroepithelial tumors (MESH:D001943), Cervical lymph node metastasis (MESH:D008207), reactive thrombocytosis (MESH:D013922), inflammatory (MESH:D007249), tracheal compression (MESH:D014133), hematological deficiencies (MESH:D019337), cachexia (MESH:D002100), breast (MESH:D061325), swelling (MESH:D004487), Stenotrophomonas maltophilia (MESH:C531821), dysphonia (MESH:D055154), dyspnea (MESH:D004417), fibroepithelial lesion (MESH:D018225), respiratory failure (MESH:D012131), sarcoma (MESH:D012509), Node (MESH:D012804), injury to (MESH:D014947), nodal (MESH:D013611), adenopathic mass (MESH:C536030), adenopathic block (MESH:D006327), thyroid neoplasms (MESH:D013964), Giant phyllodes tumors (MESH:D003557), fibroadenomas (MESH:D018226), Tumor (MESH:D009369), mesenchymal tumor (MESH:C535700), death (MESH:D003643), primary (MESH:D010538), adenopathy (MESH:D000072281), metastases (MESH:D009362), neoplastic disease (MESH:D004194)
- **Chemicals:** docetaxel (MESH:D000077143), mesna (MESH:D015080), adriamycin (MESH:D004317), trimethoprim-sulfamethoxazole (MESH:D015662), gemcitabine (MESH:D000093542), ifosfamide (MESH:D007069), Anthracycline (MESH:D018943)
- **Species:** Homo sapiens (human, species) [taxon 9606], Klebsiella oxytoca (species) [taxon 571]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13024844/full.md

---
Source: https://tomesphere.com/paper/PMC13024844